Paper4201634
Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.
Greene WH and 4 others. Ann Intern Med, 1973. Cited by 96 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center. Papers, record 4201634. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4201634
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carbenicillin | Major topic |
| Gentamicins | Major topic |
| Pseudomonas Infections | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Agranulocytosis | |
| Cephalothin | |
| Drug Combinations | |
| Enterobacteriaceae | |
| Escherichia coli | |
| Humans | |
| Penicillin Resistance | |
| Proteus mirabilis | |
| Serotyping | |
| Serratia marcescens | |
| Virulence |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 33,574,807 | Futuristic Non-antibiotic Therapies to Combat Antibiotic Resistance: A Review. | Front Microbiol | 2021 | https://conductscience.org/library/papers/33574807 | PubMed |
| 15,828,175 | Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/15828175 | PubMed |
| 7,052,229 | Prophylactic non-absorbable antibiotics in leukaemic patients. | J Hyg (Lond) | 1980 | https://conductscience.org/library/papers/7052229 | PubMed |
| 6,813,351 | Serotypes of Pseudomonas aeruginosa in clinical specimens in relation to antibiotic susceptibility. | J Clin Microbiol | 1982 | https://conductscience.org/library/papers/6813351 | PubMed |
| 6,766,295 | Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new). | Antimicrob Agents Chemother | 1980 | https://conductscience.org/library/papers/6766295 | PubMed |
| 6,638,994 | Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents. | Antimicrob Agents Chemother | 1983 | https://conductscience.org/library/papers/6638994 | PubMed |
| 6,440,473 | Regrowth of aminoglycoside-resistant variants and its possible implication for determination of MICs. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6440473 | PubMed |
| 6,436,297 | Phenotypic factors correlated with the absence of virulence among gentamicin-resistant Pseudomonas aeruginosa strains. | J Clin Microbiol | 1984 | https://conductscience.org/library/papers/6436297 | PubMed |
| 6,435,518 | In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside-resistant Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6435518 | PubMed |
| 6,372,918 | The role of the newer beta-lactam antibiotics in the treatment of infection in compromised hosts. | Bull N Y Acad Med | 1984 | https://conductscience.org/library/papers/6372918 | PubMed |
| 4,365,671 | Letter: Gentamicin-resistant escherichia coli. | Br Med J | 1974 | https://conductscience.org/library/papers/4365671 | PubMed |
| 4,157,358 | Comparison of in vitro antibacterial activities of gentamicin and verdamicin. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4157358 | PubMed |
| 4,157,347 | Comparison of the in vitro activity of BL-P1654 with gentamicin and carbenicillin against Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4157347 | PubMed |
| 4,157,342 | Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa. | Antimicrob Agents Chemother | 1974 | https://conductscience.org/library/papers/4157342 | PubMed |
| 3,640,591 | Antibiotic-resistant bacteria in surveillance stool cultures of patients with prolonged neutropenia. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3640591 | PubMed |
| 3,300,826 | Virulence versus resistance. | Bull N Y Acad Med | 1987 | https://conductscience.org/library/papers/3300826 | PubMed |
| 3,134,846 | Aminoglycoside resistance among Pseudomonas aeruginosa isolates with an unusual disk diffusion antibiogram. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3134846 | PubMed |
| 1,190,752 | Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin. | Antimicrob Agents Chemother | 1975 | https://conductscience.org/library/papers/1190752 | PubMed |
| 1,058,730 | Infections caused by gram-negative pathogens: new clinical considerations. | Bull N Y Acad Med | 1975 | https://conductscience.org/library/papers/1058730 | PubMed |
| 976,132 | Aminoglycosides: do we need new agents? | Drugs | 1976 | https://conductscience.org/library/papers/976132 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4201634
GET https://conductscience.org/api/papers/v1/4201634/cited_by?page=2